Growth Metrics

Ardelyx (ARDX) Profit After Tax Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 65.80%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -129.68%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 Ardelyx 1.48 Bn 1.25 Bn 89.66 Mn 8.60%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 8.60%
Dec 31, 2025 -108.76%
Sep 30, 2025 -19.78%
Jun 30, 2025 -15.95%
Mar 31, 2025 -55.15%
Dec 31, 2024 116.13%
Sep 30, 2024 -112.20%
Jun 30, 2024 3.90%
Mar 31, 2024 0.95%
Dec 31, 2023 -369.30%
Sep 30, 2023 128.96%
Jun 30, 2023 36.44%
Mar 31, 2023 4.62%
Dec 31, 2022 129.52%
Sep 30, 2022 47.48%
Jun 30, 2022 40.39%
Mar 31, 2022 15.33%
Dec 31, 2021 -25.48%
Sep 30, 2021 -140.71%
Jun 30, 2021 -81.07%
Mar 31, 2021 -48.19%
Dec 31, 2020 -45.91%
Sep 30, 2020 23.07%
Jun 30, 2020 2.01%
Mar 31, 2020 14.42%
Dec 31, 2019 28.97%
Sep 30, 2019 2.43%
Jun 30, 2019 -14.25%
Mar 31, 2019 -53.62%
Dec 31, 2018 -375.48%
Sep 30, 2018 -16.42%
Jun 30, 2018 13.34%
Mar 31, 2018 39.24%
Dec 31, 2017 132.34%
Sep 30, 2017 28.61%
Jun 30, 2017 10.11%
Mar 31, 2017 -19.35%
Dec 31, 2016 -83.98%
Sep 30, 2016 -60.16%
Jun 30, 2016 -417.68%
Mar 31, 2016 -570.10%
Dec 31, 2015 -328.21%
Sep 30, 2015 -24,594.59%
Jun 30, 2015 139.99%
Mar 31, 2015 -14.03%
Dec 31, 2014 7.00%
Sep 30, 2014 107.92%
Jun 30, 2014 521.21%